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The cohesin- and condensin-related SMC5/6 com-
plex has largely been studied in the context of DNA
repair. Nevertheless, SMC5/6 has an undefined
essential function even in the absence of cellular
stress. Through the use of an auxin-inducible degra-
dation system for rapidly depleting subunits of the
SMC5/6 complex, we show that SMC5/6 is essential
for viability in cancer-derived and normal human
cells. Impairment of SMC5/6 function is associated
with spontaneous induction of DNA damage, p53
activation, cell-cycle arrest, and senescence, as
well as an increased frequency of various mitotic
chromosome segregation abnormalities. However,
we show that this chromosome missegregation is
apparent only when SMC5/6 function is impaired
during the preceding S and G2 phases. In contrast,
degradation of SMC5/6 immediately prior to mitotic
entry has little or no impact on the fidelity of chromo-
some segregation, highlighting the importance of the
complex during interphase in order to ensure faithful
sister chromatid disjunction.
INTRODUCTION
Cell proliferation requires both the accurate duplication of the
genome and the faithful segregation of the newly replicated sis-
ter genomes during mitosis. During these essential processes,
the genome must undergo a series of dramatic structural
changes that rely on the concerted action of numerous proteins.
Among these proteins, members of the structural maintenance
of chromosomes (SMC) family are involved in several processes
that are important for the preservation of chromosome structure
and integrity (Wu and Yu, 2012; Zhang et al., 2019). In eukary-
otes, two SMC family members, cohesin (comprising SMC1–
SMC3 and associated subunits) and condensin (comprising
SMC2–SMC4 and associated subunits) have well-defined
roles in chromosome organization, dynamics, and stability.This is an open access article under the CC BY-NIn contrast, the third SMC family member, the SMC5/6 complex,
is highly conserved in evolution, but its role is much less well
defined (Arago´n, 2018; Fernandez-Capetillo, 2016).
SMC5/6 is made up of two core SMC proteins, SMC5 and
SMC6, as well as additional NSE (non-SMC element) subunits,
which are critical for the stability and functions of the complex.
Six NSEs (Nse1–6) are present in both budding and fission yeast.
Although only four NSEs (NSE1–4) have been described thus far in
human cells, the SLF2 (SMC5/6 localizing factor 2) protein was
suggested recently to be a functional human ortholog of yeast
Nse6 (Ra¨schle et al., 2015). Some of the NSEs have defined
catalytic roles: the heterodimer formed by NSE1/3 displays E3
ubiquitin ligaseactivity (Doyle et al., 2010),while theNSE2subunit,
which operates from its docking site on the coiled-coil region of
SMC5, possesses a Siz/PIAS-RING domain that confers E3
SUMO ligase activity (Bermu´dez-Lo´pez et al., 2015; Duan et al.,
2009; Potts and Yu, 2005). Interestingly, all of the subunits within
the complex are essential for mitotic and meiotic growth in
buddingyeast,and inactivationofeitherNse2orSmc6duringearly
development is lethal inmice (Jacome et al., 2015; Ju et al., 2013).
Under unperturbed growth conditions, budding yeast smc5/6
mutants accumulate X-shaped DNA structures that are believed
to represent some type of joint DNA molecules (JMs) (Torres-
Rosell et al., 2007). These structures are proposed to arise
because of an inability to complete DNA replication at a subset
of loci that are particularly susceptible to DNA replication pertur-
bation. This ‘‘unfinished business’’ during replication leads to an
accumulation of JMs that apparently escapedetection by theG2/
MDNAdamagecheckpoint and subsequently drives unbalanced
segregation and/ormitotic catastrophe. Indeed, smc5/6mutants
fail to efficiently segregate highly repetitive loci such as the rDNA
cluster and telomeres (Torres-Rosell et al., 2005, 2007). In agree-
ment with this, acute degradation of Smc5/6 subunits in budding
yeast leads to replication defects specific to the rDNA during the
first cell cycle (Peng et al., 2018). A second function of Smc5/6
has been proposed on the basis of the observation that following
DNA damage or DNA replication stress, smc5/6 mutants accu-
mulate unresolved homologous recombination intermediates,
highlighting a requirement for SMC5/6 in the resolution of DNA
structures that arise during recombination-coupled DNA repair
(Bermu´dez-Lo´pez et al., 2010; Pond et al., 2019).Cell Reports 31, 107533, April 21, 2020 ª 2020 The Author(s). 1
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Cells lacking a functional SMC5/6 complex display higher
rates of sister chromatid exchanges (SCEs), a readout of
crossing-over during homologous recombination repair (Kliszc-
zak et al., 2012; Stephan et al., 2011). This is a phenotype that
is characteristic of cells from individuals with Bloom’s syndrome,
which are deficient in the BLM helicase (Chu and Hickson, 2009).
However, despite their overlapping roles, and the fact that Sgs1
(the budding yeast BLM ortholog) is SUMOylated by Smc5/6,
BLM and the SMC5/6 complex appear to have largely indepen-
dent roles (Bermu´dez-Lo´pez et al., 2016; Bonner et al., 2016).
This contention is based on the fact that depletion of ySgs1/
hBLM is non-epistatic with partial loss of Smc5/6 function and
instead confers synthetic lethality/sickness (Chen et al., 2009;
Menolfi et al., 2015; Ra¨schle et al., 2015; Torres-Rosell et al.,
2005).
In order to better understand how the SMC5/6 complex con-
tributes to the maintenance of genomic stability in human cells,
we have engineered a panel of human cell lines in which it is
possible to inducibly degrade different subunits of the SMC5/6
complex. Our data indicate that SMC5/6 is essential for viability
in both cancer-derived and non-cancerous immortalized cell
lines. Loss of SMC5/6 function is associated with a greatly
increased frequency of mitotic aberrations that fuel genomic
instability, DNA damage, and ultimately cell death and senes-
cence. We show that the mitotic abnormalities seen in cells
with impaired SMC5/6 function are due to a function of the com-
plex during interphase rather than during mitosis itself.
RESULTS
Development of a System to Inducibly Degrade the
SMC5/6 Complex in Human Cell Lines
In budding and fission yeast, mutants lacking subunits of the
Smc5/6 complex are not viable (Lehmann et al., 1995). Suchmu-
tants are able to proliferate for only a limited period of time but
then arrest because of extensive chromosome abnormalities.
In mammals, it is known that NSE2 and SMC6 (Jacome et al.,
2015; Ju et al., 2013) are essential for embryonic development
in mice, although it is not known whether SMC5/6 is essential
for sustained cell proliferation in human cells. Therefore, we
investigated whether acute depletion of different subunits of
the human SMC5/6 complex had an effect on cell proliferation.
To achieve this, we endogenously modified the genes encoding
different components of the SMC5/6 complex in HCT116 cells
such that they would express the targeted subunit fused to a
minimal auxin-inducible degron (mAID) tag (Natsume et al.,
2016). These cells also constitutively express a plant-derived
E3 ubiquitin ligase, OsTIR1. In the presence of the plant hormone
3-indole-acetic acid (IAA), the interaction between OsTIR1 and
mAID is strongly enhanced, resulting in the targeted degradation
of the mAID-tagged protein. We observed that cells expressing
NSE4A-mAID alone, or those expressing NSE4A-mAID together
with SMC6-mAID, efficiently degraded the tagged subunits in
response to IAA treatment (Figures 1A, 1B, S1A, and S1B). More-
over, and as shown previously for other subunits of the human
SMC5/6 complex (Gallego-Paez et al., 2014; Potts and Yu,
2007), depletion of NSE4A alone (or in combination with
SMC6) reduced the overall stability of the full complex, as evi-2 Cell Reports 31, 107533, April 21, 2020denced by a gradual reduction in the total levels of untagged
SMC5 (Figures 1B, S1A, and S1B). The same effect was
observed in HCT116 expressing OsTIR1 under a doxycycline
promoter and SMC6-mAID-Clover (SMC6-mAC) (Figures S1C
and S1D). In support of the notion that simultaneous degradation
of both NSE4A and SMC6 destabilized the complex to a greater
extent than did degradation of either subunit alone, total levels of
the untagged SMC5 subunit were 2-fold lower in the double-de-
gron cells (Figure S1E). It should be noted that the levels of both
NSE4A-mAID and SMC6-mAID were reduced in comparison
with those in cells with untagged subunits, which we attribute
to the ability of OsTIR1 to targetmAID-tagged proteins for degra-
dation even in the absence of IAA (Figure S1F). This contention
was further supported by the fact that the levels of SMC6-mAC
were strongly reduced upon doxycycline-driven expression of
OsTIR1 (Figure S1D). We also analyzed whether degradation of
SMC5/6 might indirectly influence the stability of other SMC pro-
teins. As expected, there was no corresponding reduction in the
cellular level of cohesin (SMC1/3) or condensin (SMC2/4)
(Figure S1F).
Next, we tested whether SMC5/6 was important for continued
proliferation in either human cancer cells (HCT116) or hTERT-
immortalized non-cancer cells (RPE1). We observed that after
10 days of growth in the presence of 500 mM IAA, colony-forming
ability was reduced dramatically (Figures 1C, 1D, and S1G–S1J).
This effect was less pronounced in SMC6-mAC-expressing
cells, which can be explained by the fact that not all cells in the
population were able to degrade the protein, as confirmed by in-
direct immunofluorescence against Clover (Figures S1K–S1N).
Importantly, IAA had little or no effect on the ability of the parental
cells to form colonies (Figures S2A–S2D). Moreover, and as
shown previously in both fission and budding yeast, we
observed that cells lacking an active SMC5/6 complex were
able to proliferate for two or three cell cycles, after which the
growth rate declined rapidly (Figures 1E, S2E, and S2F; Leh-
mann et al., 1995). Therefore, we conclude that the SMC5/6
complex is essential for continued proliferation in transformed
and untransformed human cells.
Impairment of SMC5/6 Function Is Associated with
Increased DNA Damage, p53-p21 Activation, and Cell
Senescence
SMC5/6 has been shown to be important for repair of DNA dou-
ble-strand breaks (DSBs) (De Piccoli et al., 2006). We asked,
therefore, whether the inability of cells to proliferate without a
functional SMC5/6 complex might be due to an accumulation
of unrepaired (and spontaneous) DNA damage. Consistent
with this, levels of the CHK2 kinase phosphorylated at threo-
nine-68 (CHK2-T68p; a marker of ATM kinase activation) were
found to be increased upon acute co-depletion of NSE4A/
SMC6 or SMC6 in HCT116 for 24 h (Figures 2A and S2G). This
apparent accumulation of DNA damage was conserved and
was not dependent on cellular transformation, as loss of
SMC5/6 function in hTERT-RPE1 cells also generated high levels
of CHK2-T68p (Figure S2H). Staining for the canonical DNA
damage marker gH2A.X in cells treated with IAA for 4 days
further confirmed that loss of SMC5/6 leads to a slight, but sig-
nificant, increase in the levels of DNA damage in comparison
Figure 1. Subunits of the SMC5/6 Complex Are Essential in Human Colorectal Cancer Cells
(A) Outline of the strategy to endogenously tag both alleles of the NSE4A and SMC6 subunits with a minimal auxin-inducible degron (mAID).
(B) Top: protocol for assessing the timing of degradation of NSE4A and SMC6 upon addition of indole-acetic acid (IAA) to the medium. Bottom: asynchronously
growing cells were treated or not with 500 mM IAA for different periods of time, and the levels of the indicated proteins were determined using western blotting.
Note that the levels of SMC5, the other core component of the complex that is untagged, are also reduced upon auxin addition. a-Tubulin was used as a loading
control.
(C) Colony formation assay of HCT116 NSE4A-/SMC6-mAID cells after a period of 10 days of growth in the absence or the presence of 500 mM IAA.
(D) Quantification of the number of colonies from (C) relative to control from three independent experiments.
(E) Time course of cell proliferation of HCT116 NSE4A-/SMC6-mAID cells after IAA addition. The number of cells was assessed every 2 days for a total period of
7 days. Points represent the mean ± SD of three independent experiments.
See also Figures S1 and S2.with control cells (Figures 2B and 2C). However, levels of gH2A.X
in NSE4A/SMC6-degraded cells were found to be much lower
than those observed in cells treated with the DNA-damaging
agent camptothecin, a topoisomerase I inhibitor (Figures 2B
and 2C).
As persistent DNA damage can lead to cell-cycle arrest and
senescence, we asked whether cells lacking a functional SMC5/6complexmight displayaltered levels of cell-cycle arrestmarkers.
We observed that degradation of both NSE4A and SMC6 in
HCT116 cells led to a concomitant increase in the expression of
both p53 and p21, a phenomenon that was also observed in
RPE1 cells depleted for SMC6 (Figures 2A and S2H). Moreover,
and consistent with an increase in the expression of p53 and
p21, those cells that remained viable after degradation of bothCell Reports 31, 107533, April 21, 2020 3
Figure 2. Loss of SMC5/6 Induces Mild DNA Damage
(A) Western blot showing the levels of different DNA damage and cell-cycle arrest markers uponNSE4A/SMC6 degradation for different lengths of time in HCT116
NSE4A/SMC6 cells. GAPDH was used as a loading control.
(B) Representative images showing levels of gH2A.X in control, cells degraded for NSE4A/SMC6 for 4 days, and cells treated with 1 mM camptothecin (CPT) for 1
h. Scale bar, 15 mm.
(C) Quantitation of gH2A.X levels of conditions shown in (B). More than 250 cells were quantified in total per condition from three independent experiments.
Asterisks represent statistical analysis using an unpaired Student’s t test (****p < 0.0001).
(D) After 4 days of growth in the absence or presence of IAA, cells were fixed and stained for b-galactosidase to assess cellular senescence, which is indicated by
dark cytoplasmic staining. Scale bar, 10 mm.
See also Figure S3.NSE4A/SMC6 for 4 days displayed staining for b-galactosidase, a
widely usedmarker of cell senescence (Figure 2D). Hence, lack of
a functional SMC5/6 appears to generate a persistent DNA dam-
age response (DDR) that triggers the activation of the pro-
apoptotic and pro-senescence p53-p21 axis.
We therefore considered whether this alone might be the
cause of the loss of cell viability upon inactivation of SMC5/6.
To test this, we inactivated TP53 by CRISPR/Cas9-based gene4 Cell Reports 31, 107533, April 21, 2020targeting in HCT116 expressing both NSE4A-mAID and SMC6-
mAID (Figures S3A and S3B). However, we observed that these
p53-null cells still failed to form colonies following NSE4A and
SMC6 degradation (Figures S3C and S3D), despite lacking upre-
gulation of p21 (Figure S3E). Hence, we suggest that in the
absence of a functional SMC5/6 complex, the p53-p21 axis is
unlikely to be the only pathway for driving cell-cycle arrest, cell
death, and senescence.
Figure 3. Loss of SMC5/6 Subunits Leads to Chromosome Missegregation
HCT116 NSE4A-/SMC6-mAID or hTERT-RPE1 SMC6-mAID cells were grown for 24 h in the absence or presence of IAA. Anaphase cells were then analyzed for
the presence of different mitotic aberrations.
(A–F) Quantification (left) and representative anaphases (right) of cells displaying (A and B) lagging chromatin, (C and D) PICH-coated UFBs, or (E and F) chromatin
bridges. For each quantification, HCT116 cells are shown on the left and RPE cells on the right.
Mean values are shown ± SD. Error bars indicate mean ± SD of three independent experiments (120 cells were analyzed in total in each condition; 40 cells/
experiment). Asterisks represent statistical analysis using an unpaired Student’s t test (**p < 0.01, ***p < 0.001, and ****p < 0.0001).SMC5/6 Ensures Faithful Chromosome Segregation in
Human Cells
We next sought to identify the causes of the terminal phenotype
observed upon SMC5/6 degradation. SMC5/6 has been shown
to be important for accurate chromosome segregation in
different organisms, including yeast and humans (Behlke-Stei-
nert et al., 2009; Gallego-Paez et al., 2014; Payne et al., 2014).We asked, therefore, whether the terminal phenotype seen in
our SMC5/6 degron system was preceded by chromosomemis-
segregation and/or other mitotic abnormalities during mitosis.
Degradation of both NSE4A and SMC6 in HCT116 cells, or of
SMC6 alone in RPE1 cells, for 24 h led to a significant increase
in the number of cells displaying mitotic errors during anaphase
(Figure 3). The fraction of cells displaying either laggingCell Reports 31, 107533, April 21, 2020 5
(legend on next page)
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chromatin between the two segregating DNA masses in
anaphase or ultrafine DNA bridges (UFBs) coated with PICH
(defining double-stranded DNA [dsDNA]) was increased about
3-fold (Figures 3A–3D). The frequency of bulky DNA bridges
was also increased (approximately 2-fold) in cells with impaired
SMC5/6 function (Figures 3E and 3F). Therefore, degradation of
human SMC5/6 components during a single cell cycle in the
absence of additional cellular stress leads to mitotic aberrations
that might be acting as the trigger of the terminal phenotype
observed in cells with impaired SMC5/6 function. We address
this issue in more detail below.
SMC5/6 Redistributes to Specific Nuclear Regions
during Mitosis
It has been shown previously that SMC5/6 associates less prom-
inently with chromatin after cells enter mitosis (Lindroos et al.,
2006; Gallego-Paez et al., 2014). To investigate the origin of
the anaphase segregation defects following SMC5/6 degrada-
tion, we first assessed the levels of different subunits of the
SMC5/6 complex (SMC5, SMC6, and NSE4A) in the chromatin
fraction at different cell cycle stages. In order to obtain a highly
synchronized cell population, we arrested HCT116 NSE4A-/
SMC6-mAID cells with lovastatin, a cholesterol synthesis inhibi-
tor that arrests cells in G1. Cells were then released from the G1
block, and samples were taken at different time points (Figure 4).
Where required, cells were then either arrested in late G2with the
CDK1 inhibitor RO-3306 or in prometaphase with nocodazole
(Figure 4A). All of the SMC5/6 complex subunits analyzed were
found to be associated with the chromatin fraction from G1 to
mitosis (Figure 4B). In addition, levels of NSE4A-mAID, SMC6-
mAID, and untagged SMC5 remained largely constant
throughout the cell cycle. As expected, cells degraded for both
NSE4A and SMC6 during G1 showed highly reduced levels of
both subunits on chromatin. A similar effect could also be
observed for SMC5 (Figure 4B).
To confirm that the recruitment of different subunits of the
complex to chromatin was not affected by the mAID-tag used,
we followed the recruitment pattern of untagged SMC6 in wild-
type HCT116 cells at different times after a G1 release. In agree-
ment with what we observed in HCT116 NSE4A-/SMC6-mAID
cells, SMC6 was present on chromatin from G1 until mitosis,
and its association with chromatin remained similar at the
different cell cycle stages analyzed (Figures S4A and S4B).
Hence, at least in HCT116 cells, SMC5/6 can be found on chro-
matin throughout the cell cycle and does not appear to be elim-
inated from chromatin in mitosis.Figure 4. Localization of Subunits of the SMC5/6 Complex throughout
(A) FACS profiles of HCT116 NSE4A-/SMC6-mAID cells at different cell cycle sta
[Noc]).
(B) Western blot showing recruitment to chromatin of SMC6-mAID, SMC5, and
Labeling as in (A). a-Tubulin and histone H2B were used as loading controls for t
was used as a mitotic marker for cells arrested in nocodazole.
(C and D) SMC6-mAC is recruited to the nucleus in G1-, S/G2-, and G2/M-phase c
was used as a marker for S/G2 phases. Note that cyclin A is absent from G1 cel
(E and F) HCT116 Tet-OsTIR1 SMC6-mACwere grown in the absence (E) or presen
SMC6 throughout mitosis was monitored by indirect immunofluorescence using a
used as an rDNA marker. Scale bars, 5 mm.
See also Figure S4.We next sought to define the subcellular localization pattern of
SMC5/6 during the different cell cycle phases. For this, we used
HCT116 Tet-OsTIR1 SMC6-mAC cells, in which SMC6 was
endogenously tagged with mAID-Clover. In G1 and S/G2 cells,
identified as being negative and positive for cyclin A, respec-
tively, SMC6-mAC was distributed generally throughout the
nucleus (Figures 4C and 4E). As cells approached mitosis,
SMC6-mAC started to localizemore distinctly and then redistrib-
uted to specific chromatin regions during mitosis (Figure 4E).
To analyze whether SMC5/6 might localize to centromeres dur-
ing mitosis, we studied its co-localization with the centromeric
marker CREST. Strikingly, SMC6-mAC often co-localized with
CREST in mitotic cells, although it appeared to be more strongly
enriched on certain chromosomes. As SMC5/6 was previously
found to be important for the accurate segregation of the rDNA
in yeast, we analyzed whether SMC6-mAC was enriched at the
rDNA repeat regions found on the short arms of the five acrocen-
tric chromosomes (13, 14, 15, 21, and 22). Using UBF as an rDNA
marker, we observed that SMC6-mAC was highly enriched
around rDNA repeats during all stages of mitosis (Figure 4E).
This observation was further confirmed by analyzing the localiza-
tion of SMC6-mAC on chromosome spreads. Counterstaining of
chromosome spreads with CREST, UBF, and GFP showed a
clear enrichment of SMC6-mAC around the rDNA loci and, to a
lesser extent, to all centromeric regions on all chromosomes
(Figures S4C and S4D). Consistently, the signal detected by indi-
rect immunofluorescence against SMC6-mAC disappeared
upon degradation of the protein for 24 h (Figures 4D and 4F),
confirming the specificity of the antibody.
Degradation of SMC5/6 Subunits during G1, but Not
Prior Entry into Mitosis, Affects Chromosome
Segregation
Given the pattern of localization of SMC5/6 during mitosis, we
next investigated whether the mitotic aberrations seen following
SMC5/6 degradation might be due to a specific function of the
complex during mitosis. To address this, we exploited the ability
of our system to rapidly degrade both NSE4A and SMC6 in
HCT116 cells arrested at different stages of the cell cycle (Fig-
ures 5A, S5A, and S5B). Surprisingly, given the defined localiza-
tion pattern for the SMC5/6 complex inmitosis, we observed that
degradation of NSE4A and SMC6 during late G2 phase did not
increase the frequency of mitotic aberrations. In contrast, degra-
dation prior to S-phase entry gave rise to a significant increase in
the number of cells displaying mitotic aberrations (Figures
5B–5H and S5C).the Cell Cycle
ges (asynchronous [As], G1 arrested [G1], S phase [15 h], G2 [RO], and mitosis
NSE4A-mAID in the absence or presence of IAA at different cell cycle stages.
he soluble and chromatin-associated fractions, respectively. Histone H3S10p
ells in the absence of auxin (C) and is degraded after auxin addition (D). Cyclin A
ls.
ce (F) of 100 ng/mL doxycycline and 500 mM IAA for 24 h, and the localization of
n anti-GFP antibody. CREST was used as a centromeric marker, and UBF was
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Figure 5. SMC5/6 Deficiency during S Phase Affects Mitotic Chromosome Segregation
(A) Experimental workflow for assessing mitotic aberrations during anaphase upon degradation of NSE4A and SMC6 either in G1 or immediately before
mitosis.
(B) Representative images of cells displaying lagging chromatin that is either positive or negative for centromeres, marked using an anti-CENPC
antibody. H3S10p staining was used to assist in the identification of smaller fragments of condensed chromatin that were not always visible by DAPI
staining.
(C and D) Quantification of the percentage of anaphase cells displaying lagging chromatin (C) and whether the lagging chromatin was acentric or not (D).
(E and F) Representative images of anaphase cells showing chromatin DNA bridges (E) and quantification of the percentage of cells displaying chromatin DNA
bridges (F).
(legend continued on next page)
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SMC5/6 Degradation Increases UFBs Arising from
Repetitive Sequences
The SMC5/6 complex has been studied extensively for its role in
ensuring proper segregation of the rDNA locus in budding yeast
(Torres-Rosell et al., 2005). We therefore analyzed whether the
UFBs coated by PICH observed in cells lacking a functional
SMC5/6 might originate from rDNA loci or perhaps other highly
repetitive regions (Figures S5D and S5E). We observed that
impairment of SMC5/6’s function prior to entry into S phase
led to a significant increase in cells displaying PICH-coated
UFBs arising not only from the rDNA but also from centromeres.
Consistent with a lack of a role for SMC5/6 in mitosis itself, the
frequency of rDNA and centromeric UFBs was not elevated in
cells in which SMC5/6 was degraded just prior to the G2/M tran-
sition (Figure S5D). It should be noted that most anaphase cells
that went through S phase in the absence of a functional SMC5/6
complex also displayed a class of PICHUFBs that were negative
for both centromeric and rDNA markers (Figures S5D and S5E).
Inhibition of TOP2a with catalytic inhibitors such as ICRF-193
leads to an accumulation of chromatin bridges and PICH-coated
UFBs arising from centromeres, a phenotype that resembles
what we have observed in cells lacking a functional SMC5/6
complex. Recently, it has also been shown that both TOP2a
and the SMC5/6 complex interact in human cells and that
NSE2-dependent SUMOylation of TOP2a is important for accu-
rate chromosome segregation (Deiss et al., 2019). In agreement
with this proposed functional interaction between TOP2a and
SMC5/6, we observed that NSE4A-/SMC6-degraded cells dis-
played an increased level of sensitivity to low doses of ICRF-
193, as evidenced by an increase in both the frequency of
anaphase cells displaying PICH-coated UFBs and number of
PICH UFBs displayed per anaphase cell (Figures S5F–S5H).
Mitotic chromosomes of cells depleted for different SMC5/6
subunits have been shown to display either a reduction in the
levels of TOP2a or an alteration in its distribution pattern (Deiss
et al., 2019; Gallego-Paez et al., 2014). To test whether the
appearance of PICH UFBs arising from centromeres and the
rDNA in NSE4A-/SMC6-degraded cells is related to a defect in
the recruitment or retention of TOP2a on chromatin, we as-
sessed for the levels of TOP2a on mitotic chromosomes of
HCT116 cells degraded for both NSE4A and SMC6 for 24 h.
The chromatin-associated fraction of TOP2a in nocodazole-ar-
rested cells did not show any significant alterations between
control and degron cells (Figures S6A–S6C). Moreover, analysis
of the distribution of TOP2a on chromosome spreads did not
reveal any obvious abnormality (Figure S6D).
SMC5/6-Depleted Cells Display Higher Levels of
Chromosome Fragmentation, Fragility, and
Micronucleation
In order to investigate the origin of the mitotic problems in cells
depleted for NSE4A/SMC6 during G1, we assessed whether the
lagging chromatin observed in anaphase was positive for centro-(G and H) Representative images of anaphase cells displaying PICH-coated UFB
under control conditions or following SMC5/6 degradation in G1 or G2.
Meanvaluesare shown±SD.Error bars indicatemean±SDof three independentex
Asterisks represent statistical analysis using an unpaired Student’s t test (**p < 0.01mere-associated kinetochore factors. Interestingly, the lagging
chromatin in the vastmajority of cells was CENPC negative, indic-
ative of an absence of centromeric DNA (Figures 5B–5D). As this
phenomenon might be due to increased chromosome fragility,
we asked whether mitotic chromosomes of cells depleted for
NSE4AandSMC6 inG1showedan increased frequencyof breaks
or gaps. Indeed, we observed an accumulation of breaks/gaps on
metaphase chromosomeswhen the function of the SMC5/6 com-
plex was impaired prior to S-phase entry, but not when it was
compromised just prior to mitosis (Figures 6A–6D). Strikingly,
although most of the breaks/gaps found in control and in G2-
degraded cells were evident on only one sister chromatid, as is
typical for common fragile site (CFS)-associated breakage (Bhow-
mick et al., 2016; Minocherhomji et al., 2015), approximately 50%
of the breaks in SMC5/6 depleted cells involved both chromatids
when SMC5/6 was degraded in G1 (Figure 6E).
We next asked whether the abnormalities observed during
mitosis following NSE4A/SMC6 degradation were transmitted to
the next generation of daughter cells. To this end, cells depleted
for NSE4A/SMC6 either during G1 or prior to entry into mitosis
were released fromaG2block for 2 h in the presence of a concen-
tration of cytochalasin B that generated cytokinesis-blocked,
pseudo-G1 cells (Figure 7A). We observed that these daughter
cells displayed a significantly increased frequency of micronuclei
only when SMC5/6 was degraded in G1 (Figures 7B–7D).
SMC5/6 Is Not Required for Bulk DNA Replication
The phenotype displayed by cells with impaired SMC5/6 complex
function during S phase closely resembles that observed in cells
exposed toa lowdoseof theDNApolymerase inhibitor aphidicolin.
In order to test whether the chromosome fragility associated with
SMC5/6 complex degradation was a direct consequence of de-
layed DNA replication, we first tested whether NSE4A/SMC6-
depleted cells progressed through S phase with the same kinetics
as control cells. As shown by propidium iodide fluorescence-acti-
vated cell sorting (PI-FACS), cells with impaired SMC5/6 function
progressed through S phase with normal kinetics (Figures S7A
and S7B). Moreover, analysis of the phosphorylation status of
the transcription factor FoxM1 after G1 release did not show any
evidence of premature entry into mitosis, as is observed, for
example, when ATR is inhibited (Figure S7C; Saldivar et al.,
2018). To further confirm that SMC5/6 did not have an impact on
bulk DNA replication, we analyzed the speed of individual replica-
tion forks in unperturbed conditions using DNA fiber analysis. We
observed that the mean fork speed in control and NSE4A/SMC6-
degraded cells was very similar (Figures S7D–S7F).
In fission yeast, smc5/6mutants have been shown to be able to
activate the DNA damage checkpoint efficiently, although they fail
to maintain the activity of this checkpoint when the damage is
removed. As a result, these mutant cells enter mitosis with unre-
paired DNA damage that poses a problem for accurate chromo-
some segregation (Harvey et al., 2004). As discussed above, we
consistently observed that HCT116 cells degraded for boths (G) and quantification of number of anaphase cells containing these UFBs (H)
periments (120cellswere analyzed in total ineachcondition; 40cells/experiment).
, ***p < 0.001, and ****p < 0.0001). Scale bars, 5 mm. See also Figure S5.
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Figure 6. SMC5/6 Prevents Chromosome
Fragility
(A) Experimental workflow for assessing mitotic
chromosome breakage upon degradation of
NSE4A and SMC6 either in G1 or G2.
(B) Representative metaphase chromosome
spreads from cells degraded for both NSE4A and
SMC6. CENP-B box FISH was used to define
centromeric regions. Scale bar, 10 mm.
(C) Quantification of number of cells showing
breaks/gaps on mitotic chromosomes after
degradation of SMC5/6 in either G1 or G2.
(D) Quantification of number of breaks/gaps per
metaphase.
(E) Distribution of breaks/gaps on either one or
both sister chromatids of metaphase chromo-
somes.
Mean values are shown ± SD. Error bars indicate
mean ± SD of three independent experiments (150
cells were analyzed in total in each condition; 50
cells/experiment). Asterisks represent statistical
analysis using an unpaired Student’s t test
(***p < 0.001 and ****p < 0.0001).NSE4AandSMC6 inG1donot experience any delay in the cell cy-
cle, suggesting that lack of a functional SMC5/6 complex during a
single cell cycle does not lead to a level of DNAdamage that is suf-
ficient to activate the DNA damage checkpoint. However, another
possible explanation for this is that SMC5/6 deficient cells are un-
able to activate the checkpoint in the first place. To address
whether loss of SMC5/6 impairs checkpoint activation, we treated
control and NSE4A-/SMC6-degraded cells with low doses of
camptothecin upon release from lovastatin and followed their pro-
gression through the cell cycle using PI-FACS (Figure S7G).
We found that both control and NSE4A-/SMC6-degraded cells
progressed through S phase with the same kinetics in the pres-
ence of camptothecin and then became arrested at the G2/M
boundary, indicative of activation of the DNA damage checkpoint
in both cases. Monitoring of CHK1 phosphorylated at serine 34510 Cell Reports 31, 107533, April 21, 2020(CHK1-S345p) and RPA32 at serine 33
(RPA32-S33p) also revealed proficient
activation of the DNA damage checkpoint
in control and degron cells following treat-
ment with camptothecin (Figure S7H). We
conclude, therefore, that human cells
depleted for subunits of the SMC5/6 com-
plex are proficient in triggering the DNA
damage checkpoint and cell-cycle arrest.
DISCUSSION
The nature of the essential function of the
SMC5/6 complex has remained myste-
rious for several decades. Unlike the
SMC1/3 and SMC2/4 complexes, which
have been studied extensively for their
respective roles in chromosome cohesion
and condensation, defining the role(s) of
the SMC5/6 complex during DNA meta-bolism has proved more challenging. This may be because
SMC5/6 is both a structural SMC protein and an enzyme that
post-translationally modifies other proteins via its E3 SUMO
ligase and E3 ubiquitin ligase activities. Hence, SMC5/6 may
play a more diverse role during DNA metabolism than either co-
hesin or condensin.
In this study, we generated a panel of cell lines in which
different subunits of the SMC5/6 complex could be degraded
rapidly by addition of IAA to the culture medium. This allowed
us to study not only the short-term but also the long-term ef-
fects of impairing SMC5/6 function. We have shown that
degradation of either NSE4A or SMC6 destabilizes the whole
SMC5/6 complex and that this abrogates cell growth in both
HCT116 human colorectal cancer cells and hTERT-RPE1
non-cancer cells. In both cases, these cells are able to
Figure 7. Consequences of Loss of SMC5/6
in the Following G1 Phase
(A) Experimental workflow for assessing the fre-
quency of micronuclei in the following G1 phase
after degradation of NSE4A-/SMC6-mAID before
S phase or before mitosis in the preceding cell
cycle.
(B) Representative images of G1 daughter cells
displaying micronuclei of cells that have been
degraded for NSE4A/SMC6 during G1. a-Tubulin
was used to identify early G1 cells that were still
connected after cytochalasin B treatment. Lamin A
was used to show that cells had reformed the
nuclear membrane in G1.
(C) Quantification of early G1 daughter cells con-
taining at least one micronucleus.
(D) Quantification of the number of micronuclei
displayed per G1 daughter cell.
Mean values are shown ± SD. Error bars indicate
mean ± SD of three independent experiments (120
cells were analyzed in total; 40 cells/experiment).
Asterisks represent statistical analysis using an
unpaired Student’s t test (****p < 0.0001).proliferate for two or three cell generations, after which they
cease dividing, consistent with what has previously been
seen in budding and fission yeast smc5/6 mutants (Lehmann
et al., 1995). Degradation of the human SMC5/6 complex
was accompanied by an accumulation of DNA damage and
activation of p53. Nevertheless, inactivation of the TP53
gene did not rescue the lethality observed in the absence of
a functional SMC5/6. Therefore, this failure to rescue lethality
indicates that a pathway other than the p53-p21 axis must be
involved in triggering loss of proliferative capacity. Consid-
ering that lack of a functional SMC5/6 leads to an increase
in the frequency of cells with micronuclei in the ensuing G1
phase, it is conceivable that the cGAS-STING pathway trig-
gers cell-cycle arrest and senescence in cells with impaired
SMC5/6 function (Gl€uck et al., 2017). Further work will be
required to address this possibility.
One of the key questions we aimed to address by the use of
a degron system was to define the stage of the cell cycle dur-
ing which SMC5/6 function is particularly required. We have
shown that subunits of the SMC5/6 can already be found on
chromatin in G1-arrested cells and that all subunits tested
(NSE4A, SMC5, and SMC6) are present on chromatin during
S phase, G2, and mitosis. In addition, and contrary to what
was shown previously in human non-transformed hTERT-RPE1 cells (Gallego-Paez et al., 2014),
we observed that SMC5/6 redistributes
to mitotic chromatin around centro-
meres and the rDNA loci following nu-
clear envelope breakdown (NEBD).
This discrepancy might be explained
by differences in the cellular back-
ground or the approach used to detect
SMC5/6 in cells. Whereas Gallego-
Paez et al. (2014) combined indirect
immunofluorescence against SMC5with live cell imaging using SMC5-EGFP, we have assessed
the localization of SMC5/6 throughout the cell cycle by using
SMC6 endogenously tagged with mAID-Clover.
Mutation or depletion of subunits of the SMC5/6 complex is
associated with increased genomic instability seen during or after
mitosis in many eukaryotic cell types (Jacome et al., 2015; Payne
et al., 2014; Torres-Rosell et al., 2007; van der Crabben et al.,
2016). Here, we have shown that acute inactivation of SMC5/6
via degradation of both NSE4A and SMC6 in HCT116 cells or of
SMC6 in hTERT-RPE1 cells has dramatic consequences during
mitosis, with increased levels of lagging chromatin, bulky DNA
bridges, and PICH-coated UFBs after degradation of mentioned
subunits for as little as 24 h. Nevertheless, by exploiting the ability
to effect rapid degradation of SMC5/6 upon auxin addition, we
have interrogatedwhether the phenotype observedduringmitosis
is due to a role of the complex during interphase or mitosis. Sur-
prisingly, themitotic phenotype isobservedonlywhen the function
of the complex is impairedprior toS-phase entry and notwhen it is
impaired in late G2, indicating that the mitotic problems observed
are a consequence of lack of SMC5/6 during the S/G2 phases
rather than during mitosis. Furthermore, lack of SMC5/6 leads to
an increase in PICH UFBs arising from centromeres and the
rDNA, which supports the idea that SMC5/6 is not only enriched
at thesehighly repetitive regionsbutalso is required for the removalCell Reports 31, 107533, April 21, 2020 11
of a subset of unresolved DNA intertwinings. In agreement with a
role for SMC5/6 in facilitating disjunction of centromeric DNA, it
has been shown recently that TOP2a, the major enzyme required
for centromeric DNA decatenation, is SUMOylated by NSE2 and
that this process is important for proper chromosome segregation
(Deiss et al., 2019).
However, impairment of SMC5/6 functions leads to an in-
crease in PICH-coated UFBs even in cells in which TOP2a is in-
hibited, suggesting that although some crosstalk likely exists be-
tween SMC5/6 and TOP2a, these proteins also act at least
partially independently in order to ensure accurate chromosome
segregation.
We have shown that SMC5/6 impairment for one cell cycle
does not lead to decreased levels of TOP2a on chromatin or to
a change in its recruitment pattern along the chromosome scaf-
fold, as suggested previously (Deiss et al., 2019; Gallego-Paez
et al., 2014). This discrepancy can be explained by differences
in the time the cells have been dividing in absence of a functional
SMC5/6. While we have been assessing the immediate effects of
impairing the complex’s function, Gallego-Paez et al. (2014) and
Deiss et al. (2019) looked at long-term effects (e.g., two or three
cell cycles after depletion of subunits with small interfering RNAs
[siRNAs]). It is therefore possible that both the aberrant distribu-
tion of TOP2a along the chromosome arms and its complete
absence is due to an accumulation of problems upon SMC5/6
loss rather than to a direct consequence of the degradation of
subunits of the complex.
In addition, our data are in agreement with the observation that
yeast Smc5/6 is highly enriched at the rDNA locus and that it is
essential for the completion of replication of the rDNA, thus facili-
tating rDNA segregation during anaphase (Peng et al., 2018;
Torres-Rosell et al., 2005). However, even though SMC5/6 has a
very defined pattern of localization around the rDNA during
mitosis, we did not observe any obvious mitotic phenotype that
specifically involved theacrocentric chromosomesupondegrada-
tion of bothNSE4A andSMC6duringG2. This suggests that rDNA
segregation per se does not rely on a specific function of the
SMC5/6 complex duringmitosis itself. However, it cannot be ruled
out that theenrichmentofSMC5/6around the rDNArepeatsduring
mitosis reflects a function of the complex in a process other than
decatenation, such as the modulation of transcription of these
loci during mitosis and/or during the ensuing G1 phase.
NSE4A/SMC6-degraded cells display increased ‘‘sponta-
neous’’ chromosome fragility, as shown by a higher frequency of
breaks/gaps on mitotic chromosomes and of chromosome frag-
ments negative for centromeric markers in anaphase. This fragility
phenotype resembles that of cells undergoing mild replication
stress, such as exposure to a low dose of the DNA polymerase in-
hibitor aphidicolin. However, cells with impaired SMC5/6 function
do not show any delay in progression through the cell cycle
following G1 release, unlike aphidicolin-treated cells. This is in
agreement with what has been recently shown upon acute co-
depletion of both Smc6 and Nse5 during a G1 arrest in budding
yeast and supports the notion that lack of functional SMC5/6 is
not required for bulkDNA replication (Peng et al., 2018). Neverthe-
less, this does not rule out the possibility that SMC5/6 might be
important for completion of replication at a small number of spe-
cific loci such as the rDNA (Peng et al., 2018; Torres-Rosell et al.,12 Cell Reports 31, 107533, April 21, 20202005). Our observation that SMC5/6 is not essential for bulk DNA
replication differs from that reported previously in hTERT-RPE1
cells, in which a marked delay in S phase was observed (Gal-
lego-Paez et al., 2014). Again, this apparent contradiction could
be due to differences between the cellular backgrounds used in
the different studies or to differences in the experimental condi-
tions used to synchronize and degrade different subunits of
SMC5/6. Whereas Gallego-Paez et al. (2014) followed cell cycle
progression after a G0 release in cells depleted for SMC5 or
SMC6 by using siRNAs, we have used lovastatin combined with
IAA-induced degradation of NSE4A and SMC6.
If SMC5/6 were important for releasing torsional stress behind
replication forks, as it has been suggested (Kegel et al., 2011), it
would be predicted that NSE4A/SMC6-deficient cells would be
more prone to accumulate catenated sister chromatids following
DNA replication. Moreover, the accumulation of torsional stress
ahead of the advancing replication fork could be an impediment
for the replisome, whichmight increase the likelihood of conflicts
between the replication and transcription machineries and the
accumulation of R-loops. In support of this notion, budding yeast
expressing a thermosensitive allele for nse4 display increased
levels of R-loops (Chang et al., 2019). It is therefore possible
that the lack of a functional SMC5/6 complex during S phase
in human cells could lead to an accumulation of toxic levels of
R-loops and a concomitant increase in conflicts between the
replication and transcription machineries. Future studies should
be aimed at addressing the validity of this proposal.
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Antibodies
Rabbit anti-GFP (1:500, IF) Abcam Cat# ab13970, RRID:AB_300798
Mouse anti-UBF (1:200, IF) Santa Cruz Biotechnology Cat# sc-13125, RRID:AB_671403
Rabbit anti-UBTF (1:400, IF) Novus Biologicals Cat# NBP1-82545, RRID:AB_11032609
Human autoantibody against centromere
(CREST) (1:1000, IF)
Erba Diagnostics Cat# HCT-0100, RRID:AB_2744669
Guinea pig anti-PICH (1:200, IF) Purified in House Not available
Rabbit anti-Histone H3, phospho
(S10) (1:5000, WB and 1:1000, IF)
Merck Millipore Cat# 06-570, RRID:AB_310177
Mouse anti-a-tubulin (1:5000, WB
and 1:1000, IF)
Sigma-Aldrich Cat# T5168, RRID:AB_477579
Rabbit anti-lamin A (1:500, IF) Abcam Cat# ab26300, RRID:AB_775965
Mouse anti-SMC6 (1:1000, WB) Santa Cruz Biotechnology Cat# sc-365742, RRID:AB_10846328
Rabbit anti-SMC5 (1:1000, WB) Novus Biologicals Cat# NB100-469, RRID:AB 2192776
Rabbit anti-NSMCE4A (1:1000, WB) Sigma-Aldrich Cat# HPA037459, RRID:AB_10696932
Rabbit anti-GAPDH (1:2000, WB) Bethyl Laboratories Cat# A300-639A, RRID:AB_513616
Mouse anti-p53 (1:1000, WB) Santa Cruz Biotechnology Cat# sc-126, RRID:AB_628082
Rabbit anti-p21 (1:1000, WB) Cell Signaling Cat# 2947, RRID:AB_823586
Mouse anti-CHK2 (1:500, WB) Santa Cruz Biotechnology Cat# sc-17747, RRID:AB_627258
Rabbit anti-CHK2, phospho (T68)
(1:1000, WB)
Cell Signaling Cat# 2661, RRID:AB_331479
Mouse anti-CHK1 (1:500, WB) Santa Cruz Biotechnology Cat# sc-8408, RRID:AB_627257
Rabbit anti-CHK1, phospho (S345)
(1:1000, WB)
Cell Signaling Cat# 2341, RRID:AB_330023
Rabbit anti-H2B (1:5000, WB and 1:1000 IF) Abcam Cat# ab1790, RRID:AB_302612
Rabbit anti-FOXM1, phospho
(T600) (1:1000, WB)
Cell Signaling Cat# 14655, RRID:AB_2798557
Rabbit anti-SMC3 (1:1000, WB) Abcam Cat# ab128919, RRID:AB_11150430
Goat anti-TOP2a (1:500, WB) Santa Cruz Biotechnology Not available
Mouse anti-TOP2a (1:100, IF) MBL International Cat# M042-3, RRID:AB_592889
Rabbit anti-SMC2 (1:1000, WB) Abcam Cat# ab10412, RRID:AB_2192486
Guinea pig anti-CENPC (1:1000, IF) MBL International Cat# PD030, RRID:AB_10693556
Mouse anti-Cyclin A (1:500, IF) Santa Cruz Biotechnology Cat# sc-271682, RRID:AB_10709300
Rat anti-BrdU (1:200, IF) Abcam Cat# ab6326, RRID:AB_305426
Mouse anti-BrdU (1:200, IF) BD Biosciences Cat# 347580, RRID:AB_400326
Mouse anti-gH2A.X (1:200, IF) Millipore Cat# 05-636, RRID:AB_309864
Goat anti-mouse (H+L)-Peroxidase
(1:500, WB)
Sigma-Aldrich Cat# A-4416, RRID: AB_258167
Goat anti-rabbit (H+L)-Peroxidase
(1:5000, WB)
Sigma-Aldrich Cat# A-6667, RRID:AB_258307
Alexa Fluor 488 goat anti-mouse IgG
(1:500, IF)
Thermo Fisher Cat# A-11008, RRID:AB_143165
Alexa Fluor 488 goat anti-rabbit IgG
(1:500, IF)
Thermo Fisher Cat# A-11001, RRID:AB_2534069
Alexa Fluor 568 goat anti-mouse IgG
(1:500, IF)
Thermo Fisher Cat# A-11004, RRID:AB_2534072
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Alexa Fluor 568 goat anti-guinea pig
IgG (1:500, IF)
Thermo Fisher Cat# A-11075, RRID:AB 2534119
Alexa Fluor 568 goat anti-rabbit IgG
(1:500, IF)
Thermo Fisher Cat# A-11011, RRID:AB_143157
Alexa Fluor 647 goat anti-human IgG
(1:500, IF)
Thermo Fisher Cat# A-21445, RRID:AB_2535862
Alexa Fluor 647 goat anti-guinea pig
IgG (1:500, IF)
Thermo Fisher Cat# A-21450, RRID:AB_2735091
Chemicals, Peptides, and Recombinant Proteins
RO-33O6 (7 mM) APExBIO Cat# 8885
Nocodazole (3.3 mM) Sigma-Aldrich Cat# M1404
Doxycycline (100 ng/mL) Thermo Fisher Cat# 10687010
3-Indole-acetic acid (IAA) (500 mM) Abcam Cat# ab146402
Lovastatin (20 mM) SelleckChem Cat# S2061
(±)-Mevalonolactone (2 mM) Sigma-Aldrich Cat# M4667
Experimental Models: Cell Lines
HCT116 ATCC ATCC Cat# CCL-247, RRID:CVCL 0291
HCT116 CMV-OsTIR1 Natsume et al., 2016 Not available
HCT116 NSE4A-mAID This Study Not available
HCT116 NSE4A-/SMC6-mAID This Study Not available
HCT116 Tet-OsTIR1 Natsume et al., 2016 Not available
HCT116 Tet-OsTIR1 SMC6-mAID-Clover This Study Not available
hTERT-RPE1 Tet-OsTIR1 SMC6-mAID This Study Not available
Oligonucleotides
sgRNA targeting last exon of NSE4A:
TTCAGCTAGCATCAAGCACT
Not available Not available
sgRNA targeting last exon of SMC6:
GTTAAGTTACAAATCACCTT
Not available Not available
Software and Algorithms
GraphPad Prism 7 Graphpad Not available
FIJI ImageJ Not availableRESOURCE AVAILABILITY
Lead Contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Ian D.
Hickson (iandh@sund.ku.dk).
Materials Availability
All plasmids and cell lines generated in this study are available from the Lead Contact without restriction.
Data and Code Availability
Original/source data for each figure in the paper has been deposited in Mendeley (https://doi.org/10.17632/khmcnx9f22.2). This
study did not generate any unique code.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
HCT116 cells expressing either CMV-OsTIR1 or Tet-OsTIR1 from the AAVS1 locus were generated as described previously (Nat-
sume et al., 2016). Clones with homozygous insertions at the AAVS1 locus were used to make the different degron cell lines used
in the study. HCT116 CMV-OsTIR1 NSE4A-mAID were generated by co-transfecting HCT116 CMV-OsTIR1 with pX330-NSE4A-C
and NSE4A-mAID-Hygro donor. After selection with 100 mg/mL HygroGold, single colonies were isolated and homologous recom-
bination mediated knock-in of mAID at both NSE4A alleles was confirmed by genomic PCR and western blotting. To generatee2 Cell Reports 31, 107533, April 21, 2020
HCT116 CMV-OsTIR1 NSE4A-mAID SMC6-mAID cells, HCT116 CMV-OsTIR1 NSE4-mAID cells were co-transfected with pX330-
SMC6-C and SMC6-mAID-Neo donor. After selection with 700 mg/mL G418, single colonies were isolated and homologous recom-
bination knock-in ofmAID at both SMC6 alleles was confirmed by genomic PCR andwestern blot. HCT116 Tet-OsTIR1 SMC6-mAID-
mClover (-mAC) was generated by co-transfecting HCT116 Tet-OsTIR1 cells with pX330-SMC6-C and SMC6-mAID-mClover-Hygro
donor. After selection with 100 mg/mL HygroGold, colonies were isolated and homozygous insertions of the -mAC epitope at the C
terminus of both SMC6 alleles were confirmed by genomic PCR and western blot. To generate HCT116 CMV-OsTIR1 NSE4A-mAID
SMC6-mAID TP53/ the following sgRNA sequence: 50-GTCAGTCTAGGA TCGCAGCT-30 targeting the exon 2 of TP53 gene was
cloned into the pSpCas9(BB)-2A-GFP plasmid (PX458, Addgene plasmid #48138) (Ran et al., 2013). The resulting plasmid was trans-
fected into CMV-OsTIR1NSE4A-mAID SMC6-mAID and, 48h later, GFP positive cells were single sorted into 96-well plates. Different
clones were expanded and expression of p53 was assessed by western blot after treatment with 2 mM doxorubicin for 5h. Negative
clones for p53 were selected for further analysis.
hTERT-RPE1 cells expressing Tet-OsTIR1 from the ROSA26 locus were generated by co-electroporating hTERT-RPE1 (puromy-
cin-sensitive, a gift from Helfrid Hochegger) with pX330-ROSA26 and ROSA26-Tet-OsTIR1-Puro. After selection with 2 mg/mL
puromycin, single colonies were isolated and homologous recombination mediated knock-in of the Tet-OsTIR1-Puro expression
construct at one ROSA26 allele was confirmed by genomic PCR and western blotting. To generate RPE-1 Tet-OsTIR1 SMC6-
mAID cells, RPE-1 Tet-OsTIR1 cells were co-electroporated with pX330-SMC6-C and SMC6-mAID-Neo donor. After selection
with 1000 mg/mL G418, single colonies were isolated and homologous recombination knock-in of mAID at both SMC6 alleles was
confirmed by genomic PCR and western blot.
All cell lines were cultured in Dulbecco’s Modified Eagle Medium (DMEM, Thermo Fisher Scientific) supplemented with 10% fetal
bovine serum (FBS, Invitrogen, Cat# 10500), 100 U/mL penicillin and 100 mg/mL streptomycin. Cells were grown at 37C in a humid-
ified atmosphere containing 5% CO2 and were screened regularly for being mycoplasma-free.
METHOD DETAILS
Colony formation assays
250 or 2500 cells were seeded into 6-well plates, and 24h later the medium was replaced with fresh medium containing either ddH2O
or 500 mM 3-indole-acetic acid (IAA). The medium was replaced every 24h. After 10 days, colonies were washed with pre-warmed
PBS 1X and were fixed in 20% methanol/0.5% w/v crystal violet for 20 min at room temperature. Fixed colonies were washed with
PBS 1X and ddH2O, and then allowed to dry. The colonies were counted automatically using FIJI.
Cell synchronization
For cell cycle arrest in G1, cells growing either on coverslips or in flasks were incubated with lovastatin at a final concentration of
20 mM for 24h. To induce degradation of the different subunits of the SMC5/6 complex in G1, IAA was added to a final concentration
of 500 mM 4h prior releasing the cells from the lovastatin blockade. Cells were released from G1 by washing three times with pre-
warmed DMEM. Cells were allowed to enter into the cell cycle either in the absence or presence of IAA and 2 mM mevalonate
(Sigma-Aldrich). For cell cycle arrest in G2, cells released from lovastatin for 18h were treated with the CDK1 inhibitor RO-3306
(7 mM) for 3h. To induce degradation of both NSE4A-mAID and SMC6-mAID at this stage, IAA was added at the same time as
RO-3306. To assess segregation problems during anaphase, G2-arrested cells were released for 42 min and fixed. For mitotic
spreads, cells were instead released into 3.33 mM nocodazole for 1h.
Chromosome spreads and centromeric FISH
After the stated treatments, cells were collected by trypsinization, washed once with ice-cold DPBS 1X, homogenized in 5 mL ice-
cold 75 mM KCl, and were incubated on ice for 10 min. Cells were then centrifuged at 300 rcfs for 5 min at 4C, washed with 75 mM
KCl and incubated on ice for an additional 10 min. After centrifugation, swollen cells were homogenized in a small volume of 75 mM
KCl (typically 0.2-0.5 mL) and were fixed by the addition of ice-cold methanol/acetic acid (3/1) dropwise while vortexing at slow
speed. Fixed cells were kept at 20C overnight. The day after, cells were washed 4-5 times with ice-cold methanol/acetic acid,
homogenized in a small volume and spread on tilted glass slides. Slides were then dipped in methanol/acetic acid for 2h at room
temperature, air-dried, hydrated in PBS 1X for 5 min and were then fixed with 3.7% formaldehyde/PBS 1X for 10 min at room tem-
perature. After washing three times with PBS 1X for a total of 15 min, slides were dehydrated in series of cold ethanol and air-dried.
Slides were then incubated with a PNA probe specific for CENP-B box DNA (1:50, PNA Bio, Cat# F3001) in 70% formamide, 25 mM
MgCl2, 10 mM tris-HCl pH 7.4 for 3 min at 80
C (protected from the light), followed by an incubation of 2h at 37C in a humidified
chamber. After hybridization, slides were washed three times in 2X SSC/0.1% tween-20 for a total of 15 min, three times in 1X
SSC, rinsed with DNase/RNase-free H2O, dehydrated in series of cold ethanol, allowed to air dry and mounted with Vecta Shield
anti-fade mounting medium containing DAPI.
Cell cycle analysis
After indicated treatments, cells were collected by trypsinization, washed once with DPBS 1X and homogenized in a small volume of
DPBS 1X, typically 0.25-0.5 mL, before being fixed with 20C 70% ethanol, which was added dropwise while vortexing at lowCell Reports 31, 107533, April 21, 2020 e3
speed. Fixed cells were kept for at least 2h at20Cbefore being processed. After fixation, ethanol was removed by centrifugation at
500 rcfs for 5 min at 4C and cells were washed two to three times with DPBS 1X supplemented with 1% BSA. Finally, cells were
resuspended in 1 mL DPBS 1X-containing 0.04 mg/mL Propidium Iodide and 0.1 mg/mL RNase A and then incubated at 37C for
45-60 min. Cell cycle distribution analysis was performed on a FACS Calibur flow cytometer (BD Biosciences). 25000 cells were
counted per condition and data analysis was carried out by using the Cell Quest Pro software.
Preparation of protein extracts and western blotting
Cells growing in T25 flasks or 6-well plates were either collected by trypsinization or washed once with ice-cold DPBS 1X and
scraped with a cell strainer in the presence of 1-3 mL ice-cold DPBS 1X. After 5 min of centrifugation at 500 rcfs at 4C, cell pellets
were either snap frozen on dry ice or lysed by the addition of 150-200 mL of Nuclear Extraction Buffer (50 mM tris-HCl pH 8, 500 mM
NaCl, 10% glycerol, 1% NP-40, 0.1% SDS, 1 mM DTT, 0.5% sodium deoxycholate) complemented with Protease Inhibitor Cocktail
(Roche, Cat# 11836153001) and phosphatase inhibitors, PhoSTOP (Roche, Cat# 04906837001). Cell extracts were incubated on ice
for 30 min with regular vortexing and sonicated five times using a 30 s ON, 30 s OFF pulse in a Bioruptor Pico sonicator. The soluble
fraction was collected after centrifugation at > 20,000 rcfs for 20 min at 4C, and the protein concentration measured using the Pier-
ceTM BCA protein assay kit (Thermo Fisher Scientific, Cat# 23227). Samples were boiled for 5 min at 95C in NuPAGE LDS Sample
Buffer containing 100mMDTT. Unless otherwise stated, 30 mg of protein was loaded per sample. Proteins resolved on 4%–12%Bis-
Tris gel were transferred to a high-bond PVDF membrane. The membrane was blocked in 0.1% tween 20/PBS supplemented with
5%milk or 5%BSA (for detection of some phosphorylated proteins such as CHK2-T68p or CHK1-S345p) for 1h at room temperature
and incubated with the appropriate antibodies for at least 2h at room temperature or overnight at 4C. The membrane was washed
three times in 0.1% tween 20/PBS for 30 min. The membrane was incubated with appropriate secondary antibodies in the presence
of 0.1% tween 20/PBS containing 0.25%–5% milk for 1-2h at room temperature. After three washes in 0.1% tween 20/PBS, the
membrane was developed using ECL.
Chromatin fractionation
Cells growing on 10 cm dishes were washed once with DPBS 1X and trypsinized. Cells were spun at 300 rcfs for 5 min at 4C and
homogenized in buffer A (300 mM sucrose, 100 mM NaCl, 10 mM PIPES-NaOH pH 6.8, 3 mM MgCl2, 1 mM EGTA, 0.2% Triton X-
100mM) complemented with Protease Inhibitor Cocktail (Roche, Cat# 11836153001) and phosphatase inhibitors, PhoSTOP (Roche,
Cat# 04906837001). Cells were incubated on ice for 5 min and centrifuged at 1000 rcfs for 5 min at 4C. The supernatant was kept
(soluble fraction) and the resulting pellet was washed once more with buffer A and homogenized in buffer B (50 mM tris-HCl pH 7.5,
500 mMNaCl, 10% glycerol, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 1 mMDTT, 5 mM EDTA) complemented with
PIC and PhoSTOP, incubated on ice for 30 min with regular vortexing, and sonicated five times using a 30 s ON, 30 s OFF pulse in a
Bioruptor Pico sonicator. Chromatin extracts were centrifuged at > 20.000 rcfs for 20 min at 4C and the resulting fraction containing
the chromatin bound proteins was kept. Samples were boiled for 5 min at 95C in NuPAGE LDS Sample Buffer containing 100 mM
DTT and 20-30 mg of protein was loaded per sample.
DNA fibers
After specified treatments, cells were pulsed labeled with 25 mMCldU for 20 min, washed twice with pre-warmed medium, and then
pulsed labeled with 250 mM IdU for an additional 20 min. Cells were washed three times with ice-cold DPBS 1X and collected by
trypsinization. Cell pellets were homogenized in DPBS 1X to a final concentration of 2500 cells/mL. Four mL of cells were directly lysed
on microscope slides by adding 8 mL of spreading buffer (0.5% sodium dodecyl sulfate, 200 mM tris-HCl pH 7.5, 50 mM EDTA). After
2 min incubation at room temperature, the slides were tilted by 15, and the drop was allowed to slide down slowly for 2 to 5 min. The
slides were briefly air-dried for 10 min and then fixed in methanol/acetic acid (3/1) for 10 min. After fixation, the slides were washed
three times in PBS 1X, washed oncewith 2.5MHCl and denatured for 80min at room temperature with 2.5MHCl. After denaturation,
the slides were washed four times in PBS 1X, once with 0.1%Triton X-100/1%BSA/PBS 1X andwere then blocked in the same buffer
for 30 min at room temperature. Slides were subsequently incubated with rat anti-BrdU (1:200 in blocking buffer) for 75 min at room
temperature, washed once with 0.1% tween/PBS 1X, twice with PBS 1X and were then crosslinked in 4% formaldehyde/PBS 1X for
10 min. The slides were washed three times in PBS 1X and incubated for 60 min at room temperature with anti-rat Alexa Fluor 568
(1:100 in blocking buffer), washed again three times with PBS 1X and incubated overnight at 4C with mouse anti-BrdU (1:200). The
day after the slides were washed once with 0.1% tween/PBS 1X, twice with PBS 1X and incubated with anti-mouse Alexa Fluor 488
(1:100) for 60min at room temperature. Finally, slides were washed five times with PBS 1X andmounted using Vecta Shield anti-fade
mounting medium.
Immunofluorescence
Following various treatments, cells grown on coverslips were washed once with pre-warmed PBS 1X and fixed with PMEF (20 mM
PIPES-NaOH pH 6.8, 10mMEGTA, 1mMMgCl2, 3.7% formaldehyde) for 10min at room temperature. For staining of proteins bound
to chromatin, cells were instead, pre-extracted with PME containing 0.2% Triton X-100 for 1 min at room temperature, followed by
fixation with formaldehyde 3.7% for 10 min at room temperature. After fixation, cells were washed three times with PBS 1X at room
temperature and permeabilized (only when Triton X-100 was absent in the fixation buffer) with 0.15% Triton X-100/PBS 1X for 10 mine4 Cell Reports 31, 107533, April 21, 2020
at room temperature. Cells were blocked in DMEMcontaining 10%FBS and 5%BSA for at least 1h at room temperature or overnight
at 4C. After blocking, cells were incubatedwith indicated primary antibodies overnight at 4C in a humidified chamber. The day after,
cells were washed three times with 0.1% tween-20/PBS 1X at room temperature and incubated with indicated Alexa Fluor coupled
secondary antibodies for 1-2h at room temperature and protected from light. Cells were washed three times with 0.1% tween-20/
PBS 1X, counterstained with DAPI (0.2 mg/mL) and then mounted on glass slides using Vecta Shield anti-fade mounting medium.
QUANTIFICATION AND STATISTICAL ANALYSIS
No statistical methods were used to pre-determine sample size. The experiments were not randomized, and the investigators were
not blinded to allocation during experiments and outcome assessment. Unless stated, at least three independent experiments were
carried out to generate each dataset. All graphical representations of data and statistical analyses were performed using GraphPad
Prism. Error bars represent standard deviation (SD). The number of cells quantified for each experiment as well as the number of
biological replicates and p values are indicated in figures or figure legends.Cell Reports 31, 107533, April 21, 2020 e5
